Magic™ Humanized Immune Checkpoint Mice

  • Check with publisher
  • Published date: October 30, 2019
    • Shirley, New York, United States

As a leading innovator as well as a long-term dedicated service provider, Creative Biolabs has successfully launched, commercialized and optimized an exclusive Magic™ therapeutic antibody discovery platform using a variety of state-of-the-art technologies. Particularly, we now provide specialty human immune checkpoint knock-in mice to facilitate diverse immunotherapy development for our worldwide clients.

Tumor cells have multiple mechanisms to escape from host immune surveillance and elimination. One major evading mechanism is to interfere with costimulatory/inhibitory signal balance in the process of TCR activation, which can effectively induce immune suppression. This is achieved by a group of membrane proteins expressing on immune effector cells (e.g. T/B cell, NK cell). Extensive research and preclinical/clinical data highlight the promising therapeutic potential of monoclonal antibodies against those “checkpoints” to re-motivate the immune system to destroy tumors. Recently, they have gained increasing research interest, and many immune checkpoint blockers are approved by FDA or in late clinical trials. https://www.creative-biolabs.com/drug-discovery/therapeutics/humanized-immune-checkpoint-mice.htm .

Jerry Carter
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Human Antibody Production Using Transgenic Mice

    Human Antibody Production Using Transgenic Mice

    Biomedical Sciences Shirley (New York) October 30, 2019 Check with publisher

    Fully human antibodies from transgenic animals play increasingly important role in new therapeutics. Creative Biolabs has developed the Magic™ Human Antibody Discovery Platform to produce fully human monoclonal antibodies in transgenic mice. As a lea...

  • Identification of Biomarkers by ORFeome Phage Display

    Identification of Biomarkers by ORFeome Phage Display

    Biomedical Sciences Shirley (New York) October 30, 2019 Check with publisher

    The identification of biomarkers from pathogens is a prerequisite for the development of vaccines and diagnostic assays. Creative Biolabs developed an extensive and comprehensive strategy, named ORFeome phage display, for the identification of biomar...

  • Magic™ Humanized TIGIT Immune Checkpoint Knock-In Mice

    Magic™ Humanized TIGIT Immune Checkpoint Knock-In Mice

    Biomedical Sciences Shirley (New York) October 30, 2019 Check with publisher

    Immune-oncology research is greatly stimulated by the clinical success of immune checkpoint modulators which lead to the identification of new tumor immunology targets. However, drug development and assessment of immune checkpoint modulators need app...